Reaction Details |
| Report a problem with these data |
Target | Gastrin/cholecystokinin type B receptor |
---|
Ligand | BDBM85150 |
---|
Substrate/Competitor | n/a |
---|
Ki | 2398.83±n/a nM |
---|
Comments | PDSP_52 |
---|
Citation | Henke, BR; Aquino, CJ; Birkemo, LS; Croom, DK; Dougherty, RW; Ervin, GN; Grizzle, MK; Hirst, GC; James, MK; Johnson, MF; Queen, KL; Sherrill, RG; Sugg, EE; Suh, EM; Szewczyk, JW; Unwalla, RJ; Yingling, J; Willson, TM Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists. J Med Chem40:2706-25 (1997) [PubMed] Article |
---|
More Info.: | Get all data from this article |
---|
|
Gastrin/cholecystokinin type B receptor |
---|
Name: | Gastrin/cholecystokinin type B receptor |
Synonyms: | CCK-2 receptor | CCK-B receptor | CCK-BR | CCKBR | CCKRB | Cholecystokinin A | Cholecystokinin receptor | Cholecystokinin-2 Receptor | GASR_HUMAN | Gastrin/cholecystokinin type B receptor |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 48445.79 |
Organism: | Homo sapiens (Human) |
Description: | Stable expression of human CCK-2 receptors in HEK 293 cells. |
Residue: | 447 |
Sequence: | MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITL
YAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTF
IFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWL
LSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGL
ISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRS
RPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDG
PGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRAL
PDEDPPTPSIASLSRLSYTTISTLGPG
|
|
|
BDBM85150 |
---|
n/a |
---|
Name | BDBM85150 |
Synonyms: | CCK-A Agonist 25 |
Type | Small organic molecule |
Emp. Form. | C36H35N5O4 |
Mol. Mass. | 601.6942 |
SMILES | COc1ccc(cc1)N(C(C)C)C(=O)CN1c2ccccc2N(c2ccccc2)C(=O)C(Cc2nn(C)c3ccccc23)C1=O |
Structure |
|